Yu-Chin Lee

Paclitaxel plus carboplatin, compared with paclitaxel plus gemcitabine, shows similar efficacy while more cost-effective: a randomized phase II study of combination chemotherapy against inoperable non-small-cell lung cancer previously untreated.

J. Whang‐Peng, Yuh-Min Chen, R. Perng, 2002, Annals of oncology : official journal of the European Society for Medical Oncology.